A clinical study of glottic carcinoma

Kazuki Miyano, Mizuo Ando, Masafumi Yoshida, Yasuhiro Ebihara, Takahiro Asakage, Atsuro Terahara, Kazuki Miyano

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A clinical study was made of 179 patients with previously untreated glottic carcinoma registered in our department between 1998 and 2004. In our facility, T1 glottic cancer was treated by radiotherapy, T2 glottic cancer by radiotherapy or chemoradiotherapy using low-dose CDDP, and T3 and T4 glottic cancer by laryngectomy. The five-year cause-specific survival rate for glottic carcinoma was 95.1%, 96.5% for stage I, 96.6% for stage II, 92.9% for stage III, and 68.6% for stage IV. The five-year local control rate for early glottic carcinoma treated by radiotherapy was 83.1% for T1a, 60.7% for T1b, and 62.5% for T2. In T2 cases, the local control rate was 49.2% for treatment by radiotherapy, and 83.6% for low-dose CDDP with radiotherapy. Low-dose CDDP with radiotherapy contributes to high local control rate in T2 cases.

Original languageEnglish
Pages (from-to)322-326
Number of pages5
JournalToukeibu Gan
Issue number3
Publication statusPublished - 2010
Externally publishedYes


  • Glottic carcinoma
  • Larynx preservation
  • Local control
  • Low dose CDDP
  • Radiotherapy

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Oncology


Dive into the research topics of 'A clinical study of glottic carcinoma'. Together they form a unique fingerprint.

Cite this